These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 1349355

  • 1. From the Food and Drug Administration.
    Nightingale SL.
    JAMA; 1992 May 13; 267(18):2445. PubMed ID: 1349355
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [A new effective therapy of hairy cell leukemia and other lymphoproliferative diseases].
    Juliusson G, Liliemark J.
    Lakartidningen; 1991 Aug 28; 88(35):2746-9. PubMed ID: 1680209
    [No Abstract] [Full Text] [Related]

  • 6. Activity of 2-chloro-2'-deoxyadenosine in chronic lymphocytic leukemia, hairy cell leukemia, and autoimmune hemolytic anemia.
    Carson DA, Piro LD, Wasson DB, Carrera CJ, Beutler E.
    Adv Exp Med Biol; 1989 Aug 28; 253A():427-31. PubMed ID: 2576181
    [No Abstract] [Full Text] [Related]

  • 7. Rifabutin now available to patients with AIDS.
    Oncology (Williston Park); 1992 May 28; 6(5):90. PubMed ID: 1318065
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The purine analogs--a therapeutic beauty contest.
    Cheson BD.
    J Clin Oncol; 1992 May 28; 10(5):868-71. PubMed ID: 1349035
    [No Abstract] [Full Text] [Related]

  • 10. AIDS drug approved.
    J Am Osteopath Assoc; 1993 Feb 28; 93(2):261. PubMed ID: 8381779
    [No Abstract] [Full Text] [Related]

  • 11. The purine analogs--a therapeutic beauty contest.
    Cheson BD.
    J Clin Oncol; 1992 Mar 28; 10(3):352-5. PubMed ID: 1346799
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hairy cell leukemia: evaluation of the long-term outcome in 121 patients.
    Zinzani PL, Pellegrini C, Stefoni V, Derenzini E, Gandolfi L, Broccoli A, Argnani L, Quirini F, Pileri S, Baccarani M.
    Cancer; 2010 Oct 15; 116(20):4788-92. PubMed ID: 20597132
    [Abstract] [Full Text] [Related]

  • 15. The treatment of hairy cell leukemia: an update.
    Golomb HM, Ratain MJ, Mick R, Daly K.
    Leukemia; 1992 Oct 15; 6 Suppl 2():24-7. PubMed ID: 1349662
    [Abstract] [Full Text] [Related]

  • 16. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA).
    Estey EH, Kurzrock R, Kantarjian HM, O'Brien SM, McCredie KB, Beran M, Koller C, Keating MJ, Hirsch-Ginsberg C, Huh YO.
    Blood; 1992 Feb 15; 79(4):882-7. PubMed ID: 1346577
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lymphoma, hairy-cell leukemia respond to new agents.
    Oncology (Williston Park); 1992 Sep 15; 6(9):94. PubMed ID: 1449980
    [No Abstract] [Full Text] [Related]

  • 19. Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections.
    Juliusson G, Liliemark J.
    Blood; 1992 Feb 15; 79(4):888-94. PubMed ID: 1346578
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.